GoDaddy Inc.
—- Market cap
- $12.83B
- Debt
- +$3.78B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 77% equity / 23% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $12.83B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 ·
Decision snapshot: GDDY stock price vs SUPN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SUPN's multiple
Needs SUPN P/E.
Implied fair value · at GDDY's multiple
Needs EPS (TTM) is negative, GDDY P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GDDY FY 2025 (ended Dec 31, 2025) · SUPN FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 77% equity / 23% debt
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.52x
GDDY carries the larger enterprise value at $16.61B against $2.45B; GDDY trades on the lower EV / Revenue multiple (3.36x vs 3.40x); GDDY on the lower EV / EBITDA (13.05x vs 50.52x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
GoDaddy Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
SUPERNUS PHARMACEUTICALS, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
17.57x
0.04x
Net debt / EBITDA
Leverage against operating earnings
—
-1.75x
Cash and equivalents
Liquid reserves on the balance sheet
—
$128.45M
Total debt
Interest-bearing obligations outstanding
$3.78B
$43.80M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cloudflare, Inc.
GDDY vs NET
AKAMAI TECHNOLOGIES INC
GDDY vs AKAM
Wix.com Ltd.
GDDY vs WIX
VERISIGN INC/CA
GDDY vs VRSN
Jazz Pharmaceuticals plc
GDDY vs JAZZ
INCYTE CORP
GDDY vs INCY
ANI PHARMACEUTICALS INC
GDDY vs ANIP
Vanda Pharmaceuticals Inc.
GDDY vs VNDA
Harmony Biosciences Holdings, Inc.
GDDY vs HRMY
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.